We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZION:NASDAQZions Bancorporation N.A. Analysis

Data as of 2026-08-02 - not real-time

$69.70

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Zions Bancorporation’s stock is trading above its short‑term and mid‑term moving averages, supporting a bullish market direction, while the relative strength index sits near a neutral zone, indicating limited overbought pressure. The MACD histogram is in negative territory, suggesting a modest short‑term bearish bias, but the overall trend remains upward and volume is accelerating, which adds confidence to the price action. A clear support zone has been identified just above the current price, with a higher resistance level ahead, offering a defined upside corridor. The beta sits below one, implying lower volatility than the broader market, and the 30‑day price swings are moderate, while market sentiment is at an extreme greed level, reflecting strong investor appetite.
Fundamentally, Zions trades at a valuation multiple well below the industry average, coupled with a respectable dividend yield and a modest payout ratio that appears sustainable given its cash‑rich balance sheet and manageable debt profile. Strong operating margins and solid earnings growth underpin the financial health of the bank. The imminent second‑quarter earnings release and recent board appointment provide a near‑term catalyst that could sharpen price movement, but the underlying fundamentals support a positive outlook across medium and long horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Technical price above short‑term averages
  • Upcoming earnings and board change as catalysts
  • Moderate volatility with supportive volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to peers
  • Sustainable dividend and strong cash position
  • Robust operating margins and earnings growth

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent profitability and low leverage
  • Stable regional banking franchise
  • Attractive dividend yield with room for appreciation

Key Metrics & Analysis

Financial Health

Revenue Growth35.20%
Profit Margin31.76%
P/E Ratio8.9
ROE16.40%
ROA1.32%
P/B Ratio1.4
Industry P/E18.0

Technical Analysis

TrendBullish
RSI52.5
Support$67.75
Resistance$73.34
MA 20$70.20
MA 50$67.27
MA 200$60.16
MACDBearish
VolumeIncreasing
Fear & Greed Index92.88

Valuation

Target Price$74.95
Upside/Downside7.54%
GradeUndervalued
TypeValue
Dividend Yield2.75%

Risk Assessment

Beta0.95
Volatility24.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.